Luptakova Katarina
Insider CIK 1991149 · XLO Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| XLO Xilio Therapeutics, Inc. | M Exercise deriv | 2026-01-01 | 2026-01-05 | 16,625 | — | $0 | 33,250 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | M Exercise | 2026-01-01 | 2026-01-05 | 16,625 | — | $0 | 33,250 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | A Award deriv | 2025-12-31 | 2026-01-05 | 451,885 | — | $0 | 451,885 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | A Award deriv | 2025-11-21 | 2025-11-25 | 25,000 | — | $0 | 25,000 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | A Award deriv | 2025-11-21 | 2025-11-25 | 15,000 | — | $0 | 15,000 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | D To issuer deriv | 2025-11-21 | 2025-11-25 | 35,000 | — | $0 | 0 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | A Award deriv | 2025-11-21 | 2025-11-25 | 35,000 | — | $0 | 35,000 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | D To issuer deriv | 2025-11-21 | 2025-11-25 | 25,000 | — | $0 | 0 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | D To issuer deriv | 2025-11-21 | 2025-11-25 | 15,000 | — | $0 | 0 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | D To issuer deriv | 2025-11-21 | 2025-11-25 | 106,000 | — | $0 | 0 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | A Award deriv | 2025-11-21 | 2025-11-25 | 625,000 | — | $0 | 625,000 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | D To issuer deriv | 2025-11-21 | 2025-11-25 | 44,210 | — | $0 | 0 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | A Award deriv | 2025-11-21 | 2025-11-25 | 44,210 | — | $0 | 44,210 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | A Award deriv | 2025-11-21 | 2025-11-25 | 106,000 | — | $0 | 106,000 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | A Award deriv | 2025-01-01 | 2025-01-03 | 200,000 | — | $0 | 200,000 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | M Exercise deriv | 2025-01-01 | 2025-01-03 | 16,625 | — | $0 | 49,875 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | M Exercise | 2025-01-01 | 2025-01-03 | 16,625 | — | $0 | 16,625 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | A Award deriv | 2024-05-01 | 2024-05-03 | 59,333 | — | $0 | 59,333 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | A Award deriv | 2024-01-01 | 2024-01-03 | 66,500 | — | $0 | 66,500 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | A Award deriv | 2023-09-05 | 2023-09-07 | 106,000 | — | $0 | 106,000 | SEC↗ |